Cytek Biosciences Inc (NAS:CTKB)
$ 6.39 -0.14 (-2.14%) Market Cap: 841.13 Mil Enterprise Value: 572.72 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 60/100

Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 27, 2023 / 05:15PM GMT
Release Date Price: $6.18 (-2.52%)
Ross Osborn Cantor Fitzgerald;Analyst

Good afternoon, my name is Ross Osborn, I'm the MedTech, life science tools, and diagnostics analyst at Cantor. And today we have the honor of hosting Cytek Biosciences, including the CEO, Wenbin Jiang; and Patrik Jeanmonod. Apologies for the pronunciation.

But turning off, would you just provide a brief a brief background on yourselves.

Wenbin Jiang Cytek Biosciences
Inc. - CEO & Chairman of the Board

Thank you, Ross. I'm Wenbin Jiang, CEO and the Co-Founder of Cytek. And the company was founded 8.5 years ago and has been an exciting journey, and the company went public in '21.

Ross Osborn Cantor Fitzgerald;Analyst

Great.

Patrik Jeanmonod Cytek Biosciences;Ross
Inc. - CFO

And I'm Patrik Jeanmonod, I'm the CFO. I joined Cytek in 2018. I have about 20 plus years in life science industry experience working for PE-backed, VC-backed, family owned organization, early stage and late stage.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot